Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0B4OL
|
||||
| Former ID |
DNC005521
|
||||
| Drug Name |
Ac-YRMEHdFRWGSPPKD-NH2
|
||||
| Indication | Discovery agent | Investigative | [527529] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C84H119N25O21S
|
||||
| Canonical SMILES |
CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCS<br />C)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CNC=N2)C(=O)NC(CC3=CC=CC<br />=C3)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)<br />NCC(=O)NC(CO)C(=O)N6CCCC6C(=O)N7CCCC7C(=O)NC(CCCCN)C(=O<br />)NC(CC(=O)O)C(=O)N
|
||||
| InChI |
1S/C84H119N25O21S/c1-46(111)97-60(37-48-23-25-51(112)26-24-48)77(125)99-55(19-10-31-92-83(87)88)72(120)102-58(29-35-131-2)76(124)101-57(27-28-68(114)115)75(123)107-63(39-50-42-91-45-96-50)79(127)105-61(36-47-14-4-3-5-15-47)78(126)100-56(20-11-32-93-84(89)90)74(122)106-62(38-49-41-94-53-17-7-6-16-52(49)53)71(119)95-43-67(113)98-64(44-110)81(129)109-34-13-22-66(109)82(130)108-33-12-21-65(108)80(128)103-54(18-8-9-30-85)73(121)104-59(70(86)118)40-69(116)117/h3-7,14-17,23-26,41-42,45,54-66,94,110,112H,8-13,18-22,27-40,43-44,85H2,1-2H3,(H2,86,118)(H,91,96)(H,95,119)(H,97,111)(H,98,113)(H,99,125)(H,100,126)(H,101,124)(H,102,120)(H,103,128)(H,104,121)(H,105,127)(H,106,122)(H,107,123)(H,114,115)(H,116,117)(H4,87,88,92)(H4,89,90,93)/t54-,55-,56-,57-,58-,59-,60-,61+,62-,63-,64-,65-,66-/m0/s1
|
||||
| InChIKey |
XDLJELQQEILLFZ-URRWLXDFSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Melanocyte stimulating hormone receptor | Target Info | Inhibitor | [527529] | |
| Melanocortin-4 receptor | Target Info | Inhibitor | [527529] | ||
| Melanocortin-3 receptor | Target Info | Inhibitor | [527529] | ||
| Melanocortin receptor | Target Info | Inhibitor | [527529] | ||
| Pathway Interaction Database | Syndecan-3-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.